{"id":55219,"date":"2023-03-27T18:06:46","date_gmt":"2023-03-27T16:06:46","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/"},"modified":"2023-03-27T18:06:46","modified_gmt":"2023-03-27T16:06:46","slug":"french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/","title":{"rendered":"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer"},"content":{"rendered":"
\n

LYON, France–(BUSINESS WIRE)–The French Blood Establishment (EFS) and Brenus Pharma announce their strategic partnership in the bioproduction of innovative therapy drugs (ITD),<\/a> highlighting French expertise. This collaboration is part of a shared vision: developing the French bioproduction sector nationally and internationally.\n<\/p>\n

<\/a><\/p>\n

\nEFS\u2019 Cell Therapy and Engineering Unit (UTICELL)<\/a>, based in Saint-Ismier, France, shows recognized expertise in the cell therapy field since 2003 confirmed by a European GMP Certification<\/a> issued by the ANSM in 2015 for manufacturing, control and storage sites for MTIs. UTICELL also benefits from EFS\u2019 four other certified sites\u2019 expertise.\n<\/p>\n

\nBrenus\u2019s proprietary platform passed key regulatory milestones in 2022 (FDA Pre-IND, EMA Scientific-Advice) and the two synergistic entities have been collaborating effectively for several months to produce GMPs batches through a first scale-up.\n<\/p>\n

\nThis public-private partnership aims for a long-term perspective and will lead in 2023 to the production of clinical batches for the Fist-In-Human study of STC-1010, Brenus Pharma’s lead candidate, targeting colorectal cancer.\n<\/p>\n

\n“This collaboration is the result of a scientific and regulatory technical evaluation conducted with several CDMOs. The competitiveness, flexibility, and expertise of the EFS caught our attention. The UTICELL teams\u2019 knowledge bring added value to the STC-1010 project’s development, thanks to their unfailing proactivity and proposal strength,” said <\/i>Benoit Pinteur<\/i><\/a>, Brenus Pharma’s CSO<\/i>.\n<\/p>\n

\n“This collaboration reflects the importance of having both technical and scientific expertise in France to quickly advance the development of this promising drug and fulfill our public health mission. From the first exchanges with Brenus, we were impressed by the maturity of the STC-1010 project and convinced that through this collaboration, we could give patients a chance to fight their cancer,” said <\/i>Anaick MOISAN<\/i><\/a>, Pharmacist Delegate, UTICEL EFS Rh\u00f4ne-Alpes.<\/i>\n<\/p>\n

\nABOUT BRENUS\n<\/p>\n

\nBrenus Pharma is developing first-in-class tumor-antigens focused immunotherapies for solid tumors\u2019 treatment. Brenus has developed STC (Stimulated Tumor Cells), a technology platform mimicking relapsing conditions and enabling the education of patients’ immune system, to fight the resistance mechanisms of tumor cells. www.brenus-pharma.com<\/a>\n<\/p>\n

\nABOUT THE EFS\n<\/p>\n

\nEFS is the public blood service in France. We are 10,000 professionals, including doctors, nurses, biologists, technicians, pharmacists, collection teams, researchers, administrative staff\u2026 driven by the same vital mission. We are present throughout the care chain and thus give blood the power to heal. efs.sante.fr<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information: contact@brenus-pharma.com<\/a> ; charley.dubois@efs.sante.fr<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LYON, France–(BUSINESS WIRE)–The French Blood Establishment (EFS) and Brenus Pharma announce their strategic partnership in the bioproduction of innovative therapy drugs (ITD), highlighting French expertise. This collaboration is part of a shared vision: developing the French bioproduction sector nationally and internationally. EFS\u2019 Cell Therapy and Engineering Unit (UTICELL), based in Saint-Ismier, France, shows recognized expertise … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55219","6":"format-standard","7":"category-industry"},"yoast_head":"\nFrench Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LYON, France–(BUSINESS WIRE)–The French Blood Establishment (EFS) and Brenus Pharma announce their strategic partnership in the bioproduction of innovative therapy drugs (ITD), highlighting French expertise. This collaboration is part of a shared vision: developing the French bioproduction sector nationally and internationally. EFS\u2019 Cell Therapy and Engineering Unit (UTICELL), based in Saint-Ismier, France, shows recognized expertise ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T16:06:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230327005465\/en\/1747898\/21\/Logo_Brenus_Blue.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer\",\"datePublished\":\"2023-03-27T16:06:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/\"},\"wordCount\":409,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005465\\\/en\\\/1747898\\\/21\\\/Logo_Brenus_Blue.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/\",\"name\":\"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005465\\\/en\\\/1747898\\\/21\\\/Logo_Brenus_Blue.jpg\",\"datePublished\":\"2023-03-27T16:06:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005465\\\/en\\\/1747898\\\/21\\\/Logo_Brenus_Blue.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005465\\\/en\\\/1747898\\\/21\\\/Logo_Brenus_Blue.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/","og_locale":"en_US","og_type":"article","og_title":"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer - Pharma Trend","og_description":"LYON, France–(BUSINESS WIRE)–The French Blood Establishment (EFS) and Brenus Pharma announce their strategic partnership in the bioproduction of innovative therapy drugs (ITD), highlighting French expertise. This collaboration is part of a shared vision: developing the French bioproduction sector nationally and internationally. EFS\u2019 Cell Therapy and Engineering Unit (UTICELL), based in Saint-Ismier, France, shows recognized expertise ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-27T16:06:46+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230327005465\/en\/1747898\/21\/Logo_Brenus_Blue.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer","datePublished":"2023-03-27T16:06:46+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/"},"wordCount":409,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230327005465\/en\/1747898\/21\/Logo_Brenus_Blue.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/","url":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/","name":"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230327005465\/en\/1747898\/21\/Logo_Brenus_Blue.jpg","datePublished":"2023-03-27T16:06:46+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230327005465\/en\/1747898\/21\/Logo_Brenus_Blue.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230327005465\/en\/1747898\/21\/Logo_Brenus_Blue.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/french-blood-establishment-efs-brenus-pharma-partner-for-the-gmp-production-of-stc-1010-an-innovative-therapy-against-colorectal-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"French Blood Establishment (EFS) & Brenus Pharma Partner for the GMP Production of STC-1010, an Innovative Therapy Against Colorectal Cancer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55219"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55219\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}